These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13169750)

  • 1. [The significance of hyaluronidase in the rheumatic process].
    STEPANTSCHITZ G
    Wien Klin Wochenschr; 1954 Mar; 66(10):169-70. PubMed ID: 13169750
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of rheumatic diseases of the joints with hyaluronidase inhibitors].
    GIGGLBERGER H
    Dtsch Med Wochenschr; 1953 Oct; 78(42):1439-41. PubMed ID: 13107357
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study on synthetic hyaluronidase inhibitors in rheumatic arthritis].
    HAHN L; THUNE S; TRUEDSSON E
    Nord Med; 1952 Nov; 48(47):1615-9. PubMed ID: 13025921
    [No Abstract]   [Full Text] [Related]  

  • 4. Variation in serum hyaluronidase-inhibitor during treatment with 3-hydroxy-2-phenyl-cinchoninic acid.
    FABER V; IVERSEN M
    Acta Med Scand; 1952 Sep; 143(6):436-41. PubMed ID: 12976035
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-streptococcal-hyaluronidase. III. The turbidimetric determination of anti-streptococcal-hyaluronidase (ASH) in sera from patients with rheumatic fever, glomerulonephritis, tonsillitis and rheumatoid arthritis.
    FABER V
    Acta Med Scand; 1953; 147(2):121-32. PubMed ID: 13123810
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical investigation of the value of synthetic hyaluronidase inhibitors in rheumatoid arthritis.
    HAHN L; THUNE S; TRUEDSSON E
    Ann Rheum Dis; 1952 Dec; 11(4):272-6. PubMed ID: 13017477
    [No Abstract]   [Full Text] [Related]  

  • 7. [CLINICAL OBSERVATIONS ON THE THERAPEUTIC USE OF INTRA-ARTICULAR HYALURONIDASE IN CHRONIC RHEUMATIC DISEASES].
    MEINHARDT P; BOCIAN J
    Pol Tyg Lek; 1963 Jul; 18():1022-6. PubMed ID: 14073081
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of periarticular swellings with the system hyaluronic acid-hyaluronidase].
    MUNNICH A
    Dtsch Med Wochenschr; 1952 Nov; 77(45):1402-3. PubMed ID: 12988843
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of theoretic and experimental studies on the effect of thorium X and other substances on enzymatic processes, with special reference to the hyaluronic acid-hyaluronidase system].
    WILBERG C
    Arztl Wochensch; 1952 Feb; 7(6):127-9. PubMed ID: 14923468
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of hyaluronidase electrophoresis in diseases of the locomotive system].
    SANDOR R; RIESZ E
    Orv Hetil; 1956 Jan; 97(1):19-21. PubMed ID: 13297478
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyaluronidases and pathological articular fluids].
    COSTE F; BOUREL M; GALMICHE P
    C R Seances Soc Biol Fil; 1951 Jun; 145(11-12):841-4. PubMed ID: 14887128
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyaluronidase spreading test; hemoglobin in acute rheumatoid arthritis].
    MAHAUX J
    Vie Med; 1953 Jan; 34(1):19-23. PubMed ID: 13057137
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of the antistreptohyaluronidase, antistreptolysin O & antistreptokinase titers for the assessment of activity of the rheumatic process].
    ANOKHIN VN
    Ter Arkh; 1959 May; 31(5):29-40. PubMed ID: 13668927
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of localized rheumatoid diseases with hyaluronidase].
    FLUCKIGER P
    Praxis; 1952 Jun; 41(25):536-8. PubMed ID: 13003848
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyaluronidase and antihyaluronidase as permeability factors].
    GREIF S; WENNIG F
    Wien Med Wochenschr; 1953 May; 103(19-20):353-4. PubMed ID: 13078545
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of adrenalin in hyaluronidase inhibition].
    MATHIES H
    Arztl Forsch; 1958 Feb; 12(2):I/87-92. PubMed ID: 13508414
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonspecific hyaluronidase inhibitor concentrations in the blood serum of siblings and parents of children with rheumatic fever.
    ADAMS FH; CLICK D; ANDERSON R; DWAN P
    J Pediatr; 1952 Sep; 41(3):258-61. PubMed ID: 12991150
    [No Abstract]   [Full Text] [Related]  

  • 18. The significance of mucopolysaccharides in the pathogenesis of toxaemia of pregnancy. II. The effect on hyaluronidase of serum from patients with toxaemia of pregnancy.
    FEKETE S
    Acta Med Acad Sci Hung; 1957; 10(4):421-33. PubMed ID: 13497567
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dispensary services in rheumatic fever and rheumatoid arthritis].
    NAVRATIL J
    Cesk Zdrav; 1957 Jun; 5(6):353-6. PubMed ID: 13461214
    [No Abstract]   [Full Text] [Related]  

  • 20. RHEUMATIC fever and rheumatoid arthritis; transcription of a panel meeting on therapeutics.
    Bull N Y Acad Med; 1954 Nov; 30(11):863-85. PubMed ID: 13199501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.